Get the content you want anytime you want.

Latest News From Contagion® Live

Latest News

Improving Access to Patient Care & Time to Viral Suppression Using HIV Rapid Entry Programs
Implementation of a rapid entry program decreased time to first provider appointment, time to initiation of ART, and time to viral suppression in the Southern United States.
D/C/F/TAF Achieves High Virologic Response Rates Consistent Across Age, Gender, & Race Subgroups in ART-Naive HIV Patients
D/C/F/TAF achieved high virologic response rates that were overall noninferior to the control D/C+F/TDF, as well as favorable bone and renal outcomes that were consistent across age, gender, and race subgroups in phase 3 AMBER trial.
Patient Registry Cuts Rates of Post-Splenectomy Complications
An Australian study found patients were better informed and more empowered when they signed up for a national registry of spleen disease patients.
Addressing High-Concern Pathogens and Familiar Threats
Maintaining consistent environmental cleaning and disinfection is critical to warding off emerging and re-emerging pathogens.
Fighting Flu: Managing and Preventing Influenza with Antivirals
Taking into account the severity of this flu season, it is important that health care providers understand and choose the best treatment option for each patient.
Recent Recalls You Should Know About
In case you missed them, we've compiled a list of the latest US Food and Drug Administration (FDA) recalls posted this week.
Yellow Fever Vaccine Needed Before Traveling to Brazil, CDC Warns “Don't Chance It”
In the wake of news of 10 travelers being infected with yellow fever, 4 of whom have died, the Centers for Disease Control and Prevention (CDC) are urging anyone considering travel to yellow fever endemic regions of Brazil to be vaccinated prior to travel.
New Single-Tablet HIV Treatment Regimen Performs Well in Treatment-Experienced Patients Across All Race, Gender, and Age Groups
Posthoc analysis of the EMERALD trial reveal the combination regimen of D/C/F/TAF performs well in HIV-positive patients across different race, gender, and age subgroups, who may have failed previous antiviral regimens. 
The new test can differentiate between Lyme disease and 7 other tick-borne diseases.